Skip to main content

Want a detailed portfolio tracker?

Precigen (PGEN) P/E (2013 - 2026)

Precigen (PGEN) P/E from Sep 30, 2013 to Jun 3, 2026. The TTM Precigen (PGEN) P/E is -6.45. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Precigen (PGEN)

YearP/EChange
2026-6.45+15.72%
2025-5.57+134.99%
2024-2.37-37.47%
2023-3.79-129.97%
202212.64-250.65%
2021-8.39-21.15%
2020-10.64+281.89%
2019-2.79-33.39%
2018-4.18-59.85%
2017-10.42-36.63%
2016-16.45-60.43%
2015-41.57+19.57%
2014-34.77-122.42%
2013155.03N/A

Comparison Precigen (PGEN) P/E with competitors

Precigen (PGEN) P/E is -6.45.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.10-101.59%
ENLVEnlivex Therapeutics Ltd0.15-102.33%
FGENFibroGen Inc0.24-103.72%
TRAWTraws Pharma Inc0.47-107.34%
FBIOFortress Biotech Inc0.71-110.95%
CHRSCoherus Biosciences Inc0.98-115.18%
ORMPOramed Pharmaceuticals Inc1.47-122.86%
AGENAgenus Inc2.05-131.78%
VIVSVivoSim Labs Inc2.54-139.34%
INVAInnoviva Inc3.19-149.47%
CRMDCorMedix Inc3.65-156.56%
ABEOAbeona Therapeutics Inc4.20-165.24%
VXRTVaxart Inc4.26-166.12%
CVACCureVac N.V.4.45-168.97%
SRPTSarepta Therapeutics Inc4.62-171.74%
GLPGGalapagos NV4.86-175.38%
RIGLRigel Pharmaceuticals4.92-176.33%
ZVRAZevra Therapeutics Inc4.97-177.17%
ABUSArbutus Biopharma Corp5.69-188.34%
CGENCompugen Ltd7.38-214.56%
AUPHAurinia Pharmaceuticals Inc9.25-243.54%
ACADAcadia Pharmaceuticals Inc9.59-248.76%
OMEROmeros Corporation9.88-253.34%
PLXProtalix BioTherapeutics Inc9.91-253.74%
SPROSpero Therapeutics Inc10.73-266.55%
ADMAAdma Biologics Inc11.33-275.80%
SVASinovac Biotech Ltd11.44-277.43%
TBPHTheravance Biopharma Inc11.78-282.72%
HRMYHarmony Biosciences Holdings Inc12.18-288.98%
TGTXTG Therapeutics Inc13.18-304.48%
INCYIncyte Corp13.38-307.63%
SABSSAB Biotherapeutics Inc14.06-318.11%
XOMAXOMA Corp14.95-331.88%
REGNRegeneron Pharmaceuticals Inc14.98-332.42%
PBYIPuma Biotechnology Inc15.05-333.51%
EXELExelixis Inc15.79-345.06%
NAGENiagen Bioscience Inc16.35-353.75%
CPRXCatalyst Pharmaceuticals Inc17.34-369.11%
MDXGMimedx Group Inc17.38-369.58%
ARGXArgen X SE23.07-457.96%
HALOHalozyme Therapeutics Inc23.20-459.96%
XOMAOXOMA Corp25.34-493.23%
VRTXVertex Pharmaceuticals Inc25.66-498.06%
XOMAPXOMA Corp25.67-498.28%
CTMXCytomX Therapeutics Inc25.70-498.71%
ASNDAscendis Pharma A/S26.35-508.89%
RPRXRoyalty Pharma plc - Class A27.50-526.60%
SLNOSoleno Therapeutics Inc29.02-550.18%
LGNDLigand Pharmaceuticals Inc - Class B30.19-568.35%
BMRNBiomarin Pharmaceutical Inc37.51-681.94%
APLSApellis Pharmaceuticals Inc39.02-705.43%
KRYSKrystal Biotech Inc39.70-715.92%
GMABGenmab40.20-723.77%
ONCBeiGene Ltd67.03-1139.95%
TECHBio-Techne Corp68.59-1164.28%
VCELVericel Corp80.63-1350.99%
PHARPharming Group N.V.87.74-1461.32%
ALNYAlnylam Pharmaceuticals Inc124.93-2038.39%
TLXTelix Pharmaceuticals Ltd139.89-2270.45%
CORTCorcept Therapeutics Inc158.39-2557.46%